Miris

Miris is a Swedish medical technology company specializing in human milk analysis to improve neonatal care. The company's flagship product, the Miris Human Milk Analyzer (HMA), is the first and only FDA-cleared device for measuring the macronutrient content (fat, protein, and carbohydrates) and energy in breast milk. By providing precise nutritional data, Miris enables Targeted Fortification, allowing clinicians to tailor milk supplementation to the specific needs of preterm infants. The company serves neonatal intensive care units (NICUs), milk banks, and research institutions globally. Miris is headquartered in Uppsala, Sweden, and is listed on the Spotlight Stock Market.